Last updated: February 6, 2025
Sponsor: The Duchenne Registry
Overall Status: Active - Recruiting
Phase
N/A
Condition
Muscular Dystrophy
Treatment
N/AClinical Study ID
NCT02069756
DC-PPMD-2013
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of Duchenne or Becker muscular dystrophy; Manifesting female carriers andasymptomatic female carriers also included in registry.
Exclusion
Exclusion Criteria:
- Diagnosis of any other type of muscular dystrophy (including limb-girdle musculardystrophy).
Study Design
Total Participants: 10000
Study Start date:
October 01, 2007
Estimated Completion Date:
October 31, 2047
Study Description
Connect with a study center
The Duchenne Registry / PPMD
Washington, District of Columbia 20005
United StatesActive - Recruiting
The Duchenne Registry / PPMD
Hackensack, New Jersey 07601
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.